このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Pharma Foods International マネジメント

マネジメント基準チェック /24

Pharma Foods International'sの CEO はYongsook Kimで、 Nov1999年に任命され、の在任期間は 24.58年です。は、会社の株式の14.22%を直接所有しており、その価値は¥ 3.86B 。経営陣と取締役会の平均在任期間はそれぞれ4.3年と8.7年です。

主要情報

Yongsook Kim

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	24.6yrs
CEOの所有権	14.2%
経営陣の平均在職期間	4.3yrs
取締役会の平均在任期間	8.7yrs

経営陣の近況

Recent updates

We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Mar 23

CEO（最高経営責任者

Yongsook Kim (77 yo)

24.6yrs

在職期間

Mr. Mu Jo Kim, also known as Yongsook, is the Chief Executive Officer of Pharma Foods International Co., Ltd. He has been the President of Pharma Foods International Co., Ltd. since November 1999 and serve...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Mu Jo Kim	CEO, President & Director	24.6yrs	データなし	14.22% ¥ 4.0b
Noriko Horie	Head Office Sales Person & Director	no data	データなし	0.31% ¥ 86.7m
Kazuyuki Masuda	Senior MD	7.8yrs	データなし	2.55% ¥ 716.6m
Yasunori Inoue	MD, Tokyo Sales Representative & Director	no data	データなし	0.062% ¥ 17.5m
Yong-il Kim	GM of Development Department & Director	less than a year	データなし	データなし
Hirotaka Higashiyama	In Charge of Management Department & Director	less than a year	データなし	0.0022% ¥ 623.8k

4.3yrs

平均在職期間

48.5yo

平均年齢

経験豊富な経営陣: 2929の経営陣は経験豊富であると考えられます ( 4.3年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Mu Jo Kim	CEO, President & Director	no data	データなし	14.22% ¥ 4.0b
Noriko Horie	Head Office Sales Person & Director	13yrs	データなし	0.31% ¥ 86.7m
Kazuyuki Masuda	Senior MD	15.7yrs	データなし	2.55% ¥ 716.6m
Yasunori Inoue	MD, Tokyo Sales Representative & Director	4.7yrs	データなし	0.062% ¥ 17.5m
Yong-il Kim	GM of Development Department & Director	less than a year	データなし	データなし
Hirotaka Higashiyama	In Charge of Management Department & Director	less than a year	データなし	0.0022% ¥ 623.8k
Nobuo Hatta	External Auditor	10.7yrs	データなし	0.024% ¥ 6.8m
Shinya Samura	Outside Independent Director	8.7yrs	データなし	0.068% ¥ 19.0m
Takashi Iino	Head of Audit & Supervisory Board	14.7yrs	データなし	0.070% ¥ 19.7m
Shinya Tsujimoto	External Auditor	13.7yrs	データなし	0.036% ¥ 10.0m
Tetsuro Yamane	Outside Independent Director	5.7yrs	データなし	データなし
Taro Ueda	Outside Independent Director	2.7yrs	データなし	データなし

8.7yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: 2929の取締役会は経験豊富であると考えられます ( 8.7年の平均在任期間)。

Pharma Foods International マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Pharma Foods International Co., Ltd., Annual General Meeting, Oct 25, 2023

No independent directors

No independent directors

Recent updates

Third quarter 2024 earnings released: EPS: JP¥38.74 (vs JP¥68.72 in 3Q 2023)

Pharma Foods International Co., Ltd. to Report Q3, 2024 Results on Jun 10, 2024

We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending July 31, 2024

Second quarter 2024 earnings released: EPS: JP¥16.76 (vs JP¥31.44 in 2Q 2023)

Pharma Foods International Co., Ltd. to Report Q2, 2024 Results on Mar 11, 2024

Upcoming dividend of JP¥10.00 per share at 1.9% yield

Investor sentiment improves as stock rises 15%

First quarter 2024 earnings released: EPS: JP¥9.92 (vs JP¥62.76 loss in 1Q 2023)

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2024

New minor risk - Dividend sustainability

Pharma Foods International Co., Ltd. to Report Q1, 2024 Results on Dec 11, 2023

Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire Healthcare Mail Order Business Of Daicel from Daicel Corporation (TSE:4202).

Pharma Foods International Co., Ltd., Annual General Meeting, Oct 25, 2023

Full year 2023 earnings released: EPS: JP¥107 (vs JP¥12.89 loss in FY 2022)

Pharma Foods International Co., Ltd. to Report Fiscal Year 2023 Results on Sep 11, 2023

Upcoming dividend of JP¥12.00 per share at 1.2% yield

Third quarter 2023 earnings released: EPS: JP¥68.72 (vs JP¥63.54 loss in 3Q 2022)

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2023

Second quarter 2023 earnings released: EPS: JP¥31.44 (vs JP¥11.38 in 2Q 2022)

Pharma Foods International Co., Ltd. to Report Q2, 2023 Results on Mar 07, 2023

Upcoming dividend of JP¥10.00 per share

First quarter 2023 earnings released: JP¥62.76 loss per share (vs JP¥42.44 profit in 1Q 2022)

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending July 31, 2023

No independent directors

Pharma Foods International Co., Ltd. to Report Q1, 2023 Results on Dec 05, 2022

Pharma Foods International Co., Ltd. (TSE:2929) announces an Equity Buyback for 270,000 shares, representing 0.93% for ¥300 million.

Full year 2022 earnings released: JP¥12.89 loss per share (vs JP¥132 profit in FY 2021)

Pharma Foods International Co., Ltd. Declares Dividend for the Year Ended July 30, 2022, Payable on October 21, 2022

Pharma Foods International Co., Ltd. to Report Fiscal Year 2022 Results on Sep 06, 2022

Upcoming dividend of JP¥10.00 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: JP¥63.59 loss per share (vs JP¥68.78 profit in 3Q 2021)

Pharma Foods International Co., Ltd. to Report Q3, 2022 Results on Jun 03, 2022

No independent directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of JP¥10.00 per share

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS JP¥132 (vs JP¥23.76 in FY 2020)

Pharma Foods International Co., Ltd. (TSE:2929) announces an Equity Buyback for 120,000 shares, representing 0.41% for ¥300 million.

Pharma Foods International Co., Ltd. (TSE:2929) completed the acquisition of unknown majority stake in Meiji Yakuhin Co.Ltd. from Toshimitsu Ishizaka and others.

Investor sentiment improved over the past week

Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire unknown majority stake in Meiji Yakuhin Co.Ltd. from Toshimitsu Ishizaka and others.

Upcoming dividend of JP¥10.00 per share

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS JP¥68.78 (vs JP¥46.21 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS JP¥33.77 (vs JP¥25.97 loss in 2Q 2020)

New 90-day high: JP¥3,400

Pharma Foods International Co., Ltd. Enters into Exclusive Licensing Agreement with Mitsubishi Tanabe Pharma Corporation for A New Therapeutic Antibody to Treat Autoimmune Diseases

Upcoming Dividend of JP¥5.00 Per Share

Pharma Foods International Co., Ltd. to Report Q2, 2021 Results on Mar 05, 2021

First quarter 2021 earnings released: JP¥49.14 loss per share

First quarter 2021 earnings released: JP¥49.14 loss per share

Pharma Foods International Co., Ltd. to Report Fiscal Year 2020 Results on Sep 07, 2020

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24